Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

liability

Targeting’s Book of the Dead

Companies often carry harmful old genes in their DNA

- PMLiVE

Nestlé Health Science buys medical device firm

Acquisition of UK's Phagenesis expected to be completed by 2019

- PMLiVE

A rising tide

HBA Europe’s Claudia Graeve and Kathrin Schoenborn-Sobolewski on furthering women’s advancement in healthcare

- PMLiVE

Is your multichannel having the desired impact on both your customer and business?

The critical role of multichannel in delivering a differentiated customer experience and tangible business results

Brextinction

Evolution predicts tragic consequences from the UK's choice

- PMLiVE

UK pharma faces ‘immediate challenges’ following Brexit

Life science sector awaits fallout from vote to leave the European Union

- PMLiVE

Industry welcomes European diagnostics regulations

Trade bodies say they will support greater use of personalised medicines

The death of deference

We are entering an age when authority matters less

UK flag

UK needs ‘Brexit contingency plan’ to protect its science base

Action must be taken to safeguard life sciences in the country, say MPs

The fifth estate

How the media reports on the pharma industry

- PMLiVE

Explosive evolution

Companies are being forced to diversify and specialise their business models

Legal developments in product liability

With restrictive legislation and recent landmark cases, the medical industry is under increasing legal pressure

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links